
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12
Netta Mäkinen, Mervi Aavikko, Tuomas Heikkinen, et al.
PLoS Genetics (2016) Vol. 12, Iss. 2, pp. e1005850-e1005850
Open Access | Times Cited: 117
Netta Mäkinen, Mervi Aavikko, Tuomas Heikkinen, et al.
PLoS Genetics (2016) Vol. 12, Iss. 2, pp. e1005850-e1005850
Open Access | Times Cited: 117
Showing 1-25 of 117 citing articles:
Integrative genomic and transcriptomic analysis of leiomyosarcoma
Priya Chudasama, Sadaf S. Mughal, Mathijs A. Sanders, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 256
Priya Chudasama, Sadaf S. Mughal, Mathijs A. Sanders, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 256
Soft Tissue and Uterine Leiomyosarcoma
Suzanne George, César Serrano, Martee L. Hensley, et al.
Journal of Clinical Oncology (2017) Vol. 36, Iss. 2, pp. 144-150
Open Access | Times Cited: 200
Suzanne George, César Serrano, Martee L. Hensley, et al.
Journal of Clinical Oncology (2017) Vol. 36, Iss. 2, pp. 144-150
Open Access | Times Cited: 200
Uterine leiomyosarcoma: A review of the literature and update on management options
M. Roberts, Jason Aynardi, Christina Chu
Gynecologic Oncology (2018) Vol. 151, Iss. 3, pp. 562-572
Closed Access | Times Cited: 156
M. Roberts, Jason Aynardi, Christina Chu
Gynecologic Oncology (2018) Vol. 151, Iss. 3, pp. 562-572
Closed Access | Times Cited: 156
TP53 in bone and soft tissue sarcomas
Elizabeth Thoenen, Amanda Curl, Tomoo Iwakuma
Pharmacology & Therapeutics (2019) Vol. 202, pp. 149-164
Open Access | Times Cited: 111
Elizabeth Thoenen, Amanda Curl, Tomoo Iwakuma
Pharmacology & Therapeutics (2019) Vol. 202, pp. 149-164
Open Access | Times Cited: 111
Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors
Netta Mäkinen, Kati Kämpjärvi, Norma Frizzell, et al.
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 95
Netta Mäkinen, Kati Kämpjärvi, Norma Frizzell, et al.
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 95
Integrated mutational landscape analysis of uterine leiomyosarcomas
Jungmin Choi, Aránzazu Manzano, Weilai Dong, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 15
Open Access | Times Cited: 85
Jungmin Choi, Aránzazu Manzano, Weilai Dong, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 15
Open Access | Times Cited: 85
Molecular mechanisms underpinning sarcomas and implications for current and future therapy
Victoria Damerell, Michael S. Pepper, Sharon Prince
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 72
Victoria Damerell, Michael S. Pepper, Sharon Prince
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 72
ALT Positivity in Human Cancers: Prevalence and Clinical Insights
Danny MacKenzie, Andrea Watters, Julie T. To, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2384-2384
Open Access | Times Cited: 64
Danny MacKenzie, Andrea Watters, Julie T. To, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2384-2384
Open Access | Times Cited: 64
Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis
Amir Momeni Boroujeni, Elham Yousefi, Ridin Balakrishnan, et al.
Modern Pathology (2023) Vol. 36, Iss. 4, pp. 100084-100084
Closed Access | Times Cited: 24
Amir Momeni Boroujeni, Elham Yousefi, Ridin Balakrishnan, et al.
Modern Pathology (2023) Vol. 36, Iss. 4, pp. 100084-100084
Closed Access | Times Cited: 24
Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways
Tine Cuppens, Matthieu Moisse, Jeroen Depreeuw, et al.
International Journal of Cancer (2017) Vol. 142, Iss. 6, pp. 1230-1243
Open Access | Times Cited: 77
Tine Cuppens, Matthieu Moisse, Jeroen Depreeuw, et al.
International Journal of Cancer (2017) Vol. 142, Iss. 6, pp. 1230-1243
Open Access | Times Cited: 77
Integrated genetic and epigenetic analysis of myxofibrosarcoma
Koichi Ogura, Fumie Hosoda, Yasuhito Arai, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 74
Koichi Ogura, Fumie Hosoda, Yasuhito Arai, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 74
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile
Annalisa Astolfi, Margherita Nannini, Valentina Indio, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2126-2126
Open Access | Times Cited: 67
Annalisa Astolfi, Margherita Nannini, Valentina Indio, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2126-2126
Open Access | Times Cited: 67
Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma
Hideaki Tsuyoshi, Yoshio Yoshida
Cancer Science (2018) Vol. 109, Iss. 6, pp. 1743-1752
Open Access | Times Cited: 66
Hideaki Tsuyoshi, Yoshio Yoshida
Cancer Science (2018) Vol. 109, Iss. 6, pp. 1743-1752
Open Access | Times Cited: 66
Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience
Gregory M. Coté, Jie He, Edwin Choy
The Oncologist (2017) Vol. 23, Iss. 2, pp. 234-242
Open Access | Times Cited: 65
Gregory M. Coté, Jie He, Edwin Choy
The Oncologist (2017) Vol. 23, Iss. 2, pp. 234-242
Open Access | Times Cited: 65
Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors
Sabrina Croce, Agnès Ducoulombier, Agnès Ribeiro, et al.
Modern Pathology (2018) Vol. 31, Iss. 5, pp. 816-828
Open Access | Times Cited: 61
Sabrina Croce, Agnès Ducoulombier, Agnès Ribeiro, et al.
Modern Pathology (2018) Vol. 31, Iss. 5, pp. 816-828
Open Access | Times Cited: 61
Solid tumours hijack the histone variant network
Flávia G. Ghiraldini, Dan Filipescu, Emily Bernstein
Nature reviews. Cancer (2021) Vol. 21, Iss. 4, pp. 257-275
Open Access | Times Cited: 55
Flávia G. Ghiraldini, Dan Filipescu, Emily Bernstein
Nature reviews. Cancer (2021) Vol. 21, Iss. 4, pp. 257-275
Open Access | Times Cited: 55
Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss
Douglas I. Lin, Amanda Hemmerich, Claire Edgerly, et al.
Gynecologic Oncology (2020) Vol. 157, Iss. 2, pp. 357-366
Closed Access | Times Cited: 51
Douglas I. Lin, Amanda Hemmerich, Claire Edgerly, et al.
Gynecologic Oncology (2020) Vol. 157, Iss. 2, pp. 357-366
Closed Access | Times Cited: 51
Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Josephine K. Dermawan, Sarah Chiang, Samuel Singer, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 10, pp. 2260-2271
Open Access | Times Cited: 8
Josephine K. Dermawan, Sarah Chiang, Samuel Singer, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 10, pp. 2260-2271
Open Access | Times Cited: 8
Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases
Jennifer A. Bennett, Britta Weigelt, Sarah Chiang, et al.
Modern Pathology (2017) Vol. 30, Iss. 10, pp. 1476-1488
Open Access | Times Cited: 61
Jennifer A. Bennett, Britta Weigelt, Sarah Chiang, et al.
Modern Pathology (2017) Vol. 30, Iss. 10, pp. 1476-1488
Open Access | Times Cited: 61
Combination Approach for Detecting Different Types of Alterations in Circulating Tumor DNA in Leiomyosarcoma
Joanna Przybył, Jacob J. Chabon, Lien Spans, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 11, pp. 2688-2699
Open Access | Times Cited: 49
Joanna Przybył, Jacob J. Chabon, Lien Spans, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 11, pp. 2688-2699
Open Access | Times Cited: 49
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis
Rita T. Lawlor, Nicola Veronese, Antonio Pea, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 48
Rita T. Lawlor, Nicola Veronese, Antonio Pea, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 48
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells
Eros Di Giorgio, Emiliano Dalla, Elisa Franforte, et al.
Nucleic Acids Research (2019) Vol. 48, Iss. 2, pp. 646-664
Open Access | Times Cited: 44
Eros Di Giorgio, Emiliano Dalla, Elisa Franforte, et al.
Nucleic Acids Research (2019) Vol. 48, Iss. 2, pp. 646-664
Open Access | Times Cited: 44
Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation
Pier Selenica, Niamh Conlon, Carlene Gonzalez, et al.
The American Journal of Surgical Pathology (2020) Vol. 45, Iss. 1, pp. 77-92
Open Access | Times Cited: 41
Pier Selenica, Niamh Conlon, Carlene Gonzalez, et al.
The American Journal of Surgical Pathology (2020) Vol. 45, Iss. 1, pp. 77-92
Open Access | Times Cited: 41
Uterine PEComas: correlation between melanocytic marker expression and TSC alterations/TFE3 fusions
Jennifer A. Bennett, Zehra Ordulu, André Pinto, et al.
Modern Pathology (2021) Vol. 35, Iss. 4, pp. 515-523
Open Access | Times Cited: 35
Jennifer A. Bennett, Zehra Ordulu, André Pinto, et al.
Modern Pathology (2021) Vol. 35, Iss. 4, pp. 515-523
Open Access | Times Cited: 35
Targeting homologous recombination deficiency in uterine leiomyosarcoma
Genevieve Dall, Cassandra J. Vandenberg, Ksenija Nesic, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 14
Genevieve Dall, Cassandra J. Vandenberg, Ksenija Nesic, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 14